Abstract
Poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles loaded with lamivudine and coated with bovine serum albumin (BSA) were prepared via a double emulsion method. The influences of experiments parameters such as volume of inner aqueous phase, concentration of organic phase and ultrasonication time on the particle size and drug entrapment efficiency were investigated, obtaining PLGA particles with a diameter of ∼260 nm and drug entrapment efficiency of ∼35%. The particles were observed by scanning electron microscopy and transmittance electron microscopy, showing a core-shell structure. BCA assay found that 58 mg BSA was present on/in 1 g LPB particles. The loaded lamivudine showed a burst release at beginning and sustained release until 24 h in physiological conditions. Low pH could accelerate the release of lamivudine from PLGA particles, making the PLGA particles potential intelligent intracellular drug carriers. The PLGA particles were readily internalized into the human liver cells within a short time and increased gradually with the prolongation of incubation time regardless of the loading of lamivudine. The particles either resided within lysosomes or transferred to cytoplasm, but could not enter into the cell nucleus. The cell viability was not significantly influenced in the presence of the particles regardless of lamivudine encapsulation, suggesting that this kind of particles may be a good candidate for the intracellular anti-hepatitis B drug delivery.
Article PDF
Similar content being viewed by others
References
Hildt E, Hofschneider P H, Urban S. The role of hepatitis B virus (HBV) in the development of hepatocellular carcinoma. Semin Virol, 1996, 7: 333–347
Lai C L, Ratziu V, Yuen M F, et al. Viral hepatitis B. Lancet, 2003, 362: 2089–2094
Ye L, Zhang Y, Mei Y, et al. Detecting putative recombination events of hepatitis B virus: An updated comparative genome analysis. Chin Sci Bull, 2010, 55: 2373–2379
Doong S L, Tsai C H, Schinazi R F. Inhibition of the replication of hepatitis B virus in vitro by 2′,3′-dideoxy-3′-thiacytidine and related analogues. Proc Natl Acad Sci USA, 1991, 88: 8495–8499
Bartholomew M M, Jansen R W, Jeffers L J. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet, 1997, 349: 20–22
Fox Z, Dragsted U B, Gerstoft J. A randomized trial to evaluate continuation versus discontinuation of lamivudine in individuals failing a lamivudine-containing regimen: The COLATE trial. Antivir Ther, 2006, 11: 761–770
Kuo Y C, Chen H H. Effect of nanoparticulate polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate on the permeability of zidovudine and lamivudine across the in vitro blood-brain barrier. Int J Pharm, 2006, 327: 160–169
Li Q, Du Y Z, Yuan H. Synthesis of lamivudine stearate and antiviral activity of stearic acid-g-chitosan oligosaccharide polymeric micelles delivery system. Eur J Pharm Sci, 2010, 41: 498–507
Chimalakonda K C, Agarwal H K, Kumar A. Synthesis, analysis, in vitro characterization, and in vivo disposition of a lamivudine-dextran conjugate for selective antiviral delivery to the liver. Bioconj Chem, 2007, 18: 2097–2108
Dutta T, Jain N K. Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly(propyleneimine) dendrimer. BBA-General Subjects, 2007, 1770: 681–686
Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliver Rev, 2003, 55: 329–347
Zhang Y, Hu L, Gao C. Effect of cellular uptake of SiO2 particles on adhesion and migration of HepG2 cells. Acta Polym Sin, 2009, 815–822
Brannon-Peppas L, Blanchette J O. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliver Rev, 2004, 56: 1649–1659
Hu L, Zhang Y, Gao C. Influence of structures and properties of polymer nanoparticles on their cellular uptake and cell functions. Prog Chem, 2009, 21: 1254–1267
Yang H, Miyoshi H, Lou C, et al. Preparation, characterization and release of methyl viologen from a novel nanoparticle delivery system with double shells of silica and PLGA. Chin Sci Bull, 2010, 55: 263–267
Faisant N, Akiki J, Siepmann F. Effect of the type of release medium on drug release from PLGA-based microparticles: Experiment and theory. Int J Pharm, 2006, 314: 189–197
Siepmann J, Faisant N, Akiki J. Effect of the size of biodegradable microparticles on drug release: Experiment and theory. J Control Release, 2004, 96: 123–134
Hu L, Mao Z, Gao C. Colloidal particles for cellular uptake and delivery. J Mater Chem, 2009, 19: 3108–3115
Mundargi R C, Babu V R, Vidhya R. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. J Control Release, 2008, 125: 193–209
Cu Y, LeMoellic C, Caplan M J. Ligand-modified gene carriers increased uptake in target cells but reduced DNA release and transfection efficiency. Nanomed: Nanotechnol Biol Med, 2009, 6: 1–10
Zhou S, Sun J, Sun L. Preparation and characterization of interferon-loaded magnetic biodegradable microspheres. J Biomed Mater Res B, 2008, 87B: 190–195
Zambaux M F. Preparation and characterization of protein C-loaded PLA nanoparticles. J Control Release, 1999, 60: 179–188
Gorner T, Gref R, Michenot D. Lidocaine-loaded biodegradable nanospheres. I. Optimization of the drug incorporation into the polymer matrix. J Control Release, 1999, 57: 259–268
Zhou J, Moya S, Gao C. Folic acid modified poly(lactide-co-glycolide) nanoparticles, layer-by-layer surface engineered for targeted delivery. Macromol Chem Phys, 2010, 211: 404–411
Zhou J, Moya S, Gao C. Layer by layer chitosan/alginate coatings on poly(lactide-co-glycolide) nanoparticles for antifouling protection and Folic acid binding to achieve selective cell targeting. J Colloid Interf Sci, 2010, 345: 241–247
Zhou J, Moya S, Gao C. Polyelectrolyte coated PLGA nanoparticles: Templation and release behavior. Macromol Biosci, 2009, 9: 326–335
Bilati U, Mann E A, Doelker E. Poly(D,L-lactide-co-glycolide) protein-loaded nanoparticlesprepared by the double emulsion method—Processing and formulation issues for enhanced entrapment efficiency. J Microencapsul, 2005, 22: 205–214
Xie L, Tong W, Xu J, et al. Multilayers and poly(allylamine hydro chloride)-graft-poly(ethylene glycol) modified bovine serum albumin nanoparticles: Improved stability and pH-responsive drug delivery. Chin J Polym Sci, 2012, 30: 719–726
Feng Z, Gao C, Shen J. Fabrication and characterization of gold nanoparticles loaded microcapsules. Acta Polym Sin, 2008, 8: 823–827
Li J, Li L, Cao H. Establishment of highly differentiated immortalized human hepatocyte line with simian virus 40 large tumor antigen for liver based cell therapy. ASAIO J, 2005, 51: 261–268
Bilati U, Allemann E, Doelke E. Sonication parameters for the preparation of biodegradable nanocapsules of controlled size by the double emulsion method. Pharm Dev Technol, 2003, 8: 1–9
Chung T H, Wu S, Yao M. The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. Biomaterials, 2007, 28: 2959–2966
Zhang Y, Hu L, Yu D, et al. Influence of silica particle internalization on adhesion and migration of human dermal fibroblasts. Biomaterials, 2010, 31: 8465–8474
Hillaireau H, Couvreur P. Nanocarriers’ entry into the cell: Relevance to drug delivery. Cell Mol Life Sci, 2009, 66: 2873–2896
Author information
Authors and Affiliations
Corresponding authors
Additional information
This article is published with open access at Springerlink.com
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Wang, B., Chen, G., Mao, Z. et al. Preparation and cellular uptake of PLGA particles loaded with lamivudine. Chin. Sci. Bull. 57, 3985–3993 (2012). https://doi.org/10.1007/s11434-012-5419-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11434-012-5419-1